E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 2/19/2015 in the Prospect News PIPE Daily.

HCi Viocare sells $19,411 of common shares through private placement

Lone investor purchases 8,225 of the company’s shares at $2.36 apiece

By Devika Patel

Knoxville, Tenn., Feb. 19 – HCi Viocare completed a $19,411 private placement of stock with an investor on Feb. 17, according to an 8-K filed Thursday with the Securities and Exchange Commission.

The company sold 8,225 common shares at $2.36 per share. The price per share reflects a 25.08% discount to the Feb. 13 closing share price of $3.15.

The development-stage company is based in Glasgow. It is working to create a chain of prosthetics and orthotics and diabetic foot clinics in Europe and the Middle East and developing a portfolio of biomedical technologies in the diabetic foot, prosthetics and orthotics and other health and wellbeing areas.

Issuer:HCi Viocare
Issue:Common stock
Amount:$19,411
Shares:8,225
Price:$2.36
Warrants:No
Settlement date:Feb. 17
Stock symbol:OTCBB: VICA
Stock price:$3.15 at close Feb. 13
Market capitalization:$18.71 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.